Dornase Alfa- (Recombinant human deoxyribonuclease -DNase -@- Mucoltytics- Respiratory Inhalant Products
Drug Name:
Dornase Alfa- (Recombinant human deoxyribonuclease -DNase -@- Mucoltytics- Respiratory Inhalant Products
List Of Brands:
Indication Type Description:
Indication:
Cystic fibrosis
Adverse Reaction:
Adverse reactions-
Voice alteration 10% pharyngitis 34% chest pain 15%
Contra-Indications:
Known hypersensitivity - chinese hamster ovary cell products or any component of the product
Special Precautions-
Pregnancy- this drug should be used during pregnancy if cleraly needed
Lactation- caution should be excercised when dornase alfa is administereed to a nursing
woman
Children- its use should be considered only if there is a potential benefit in pulmonary function
or in risk of respiratory tract infection
Dosages/ Overdosage Etc:
Indication-
Cystic fibrosis
Dosage-
Recommended dose - one 2.5mg single use ampule inhaled once daily using a recommended
nebulizer
Patient Information:
1. Dornase Alfa contains no preservative, and once opened the entire contents of the ampule
must be used or discraded.
2. Patients should be instructed about the proper use and maintenance of the nebulizer and
compressor system.
3. Dornase must not be diluted or mixed other drugs in the nebulizer.
Mixing of dornase alfa with other drugs could lead to adverse physical/chemical
and/or functional changes in dornase alfa or the admixed compound
Pregnancy and lactation:
Pregnancy-
This drug should be used during pregnancy if cleraly needed
Lactation-
Caution should be excercised when dornase alfa is administereed to a nursing
woman
Children-
Its use should be considered only if there is potential benefit in pulmonary function
or in risk of respiratory tract infection